Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 12/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.83 |
| ▸ | HPGD | P15428 | 9/20 | 0.83 |
| ▸ | HSD17B10 | Q99714 | 9/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.83 |
| ▸ | MAPT | P10636 | 7/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.76 |
| ▸ | TP53 | P04637 | 4/20 | 0.76 |
| ▸ | MAOA | P21397 | 3/20 | 0.76 |
| ▸ | MAOB | P27338 | 3/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.76 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.76 |
| ▸ | BCL2 | P10415 | 1/20 | 0.76 |
| ▸ | IL2 | P60568 | 1/20 | 0.76 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.76 |
| ▸ | PPARG | P37231 | 2/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xenognosin B SCHEMBL30851576 | 1.00 | KDM4E (0.83) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL2971118 | 0.94 | XDH (0.76) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL9992779 | 0.92 | KDM4E (0.76) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| 2'-Methoxyformonetin SCHEMBL29777010 | 0.91 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| 2'-Methoxyformonetin SCHEMBL234355 | 0.91 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL72610 | 0.87 | KDM4E (0.72) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL31134786 | 0.87 | KDM4E (0.72) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| SCHEMBL29737520 | 0.87 | KDM4E (0.72) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| Formononetin SCHEMBL15271536 | 0.86 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 | |
| Formononetin SCHEMBL29361145 | 0.86 | KDM4E (1.00) | KDM4EALDH1A1HPGDHSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20120003273-A1 | SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860)) (IN) | 2012-01-05 | — | — | US | claimed |
| EP-2346844-A1 | SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS | Council Of Scientific & Industrial Research (IN) | 2011-07-27 | — | — | EP | claimed |
| WO-2010052734-A1 | SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-05-14 | — | — | WO | claimed |
| US-20020177527-A1 | Methods for the identification of inhibitors of 2'-hydroxyisoflavone reductase expression or activity in plants | ICORIA, INC. | 2002-11-28 | — | — | US | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| WO-2025049925-A2 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | POSEIDA THERAPEUTICS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | disclosed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240355451-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | NESTLE SA (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-4391834-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2024-07-03 | — | — | EP | disclosed |
| EP-1263937-A2 | RECOMBINANT PINORESINOL/LARICIRESINOL REDUCTASE, RECOMBINANT DIRIGENT PROTEIN, AND METHODS OF USE | Washington State University Research Foundation (US) | 2002-12-11 | — | — | EP | disclosed |
| US-20020177527-A1 | Methods for the identification of inhibitors of 2'-hydroxyisoflavone reductase expression or activity in plants | ICORIA, INC. | 2002-11-28 | — | — | US | disclosed |
| WO-2002092776-A2 | METHODS FOR THE INDENTIFICATION OF INHIBITORS OF 2-HYDROXYISOFLAVONE REDUCTASE EXPRESSION OR ACTIVITY IN PLANTS | BAYER CROPSCIENCE AG (DE) | 2002-11-21 | — | — | WO | disclosed |
| WO-2001049833-A2 | RECOMBINANT PINORESINOL/LARICIRESINOL REDUCTASE, RECOMBINANT DIRIGENT PROTEIN, AND METHODS OF USE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2001-07-12 | — | — | WO | disclosed |
| US-6210942-B1 | USEFUL AS POLYMERASE CHAIN REACTION PRIMERS, OR AS PROBES FOR PINORESINOL/LARICIRESINOL REDUCTASE GENES, DIRIGENT PROTEIN GENES, OR RELATED GENES | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION | 2001-04-03 | — | — | US | disclosed |
| US-5750399-A | CONTROL TRANSCRIPTION IN PLANTS | THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) | 1998-05-12 | — | — | US | disclosed |
| EP-0792356-A1 | ISOFLAVONE REDUCTASE PROMOTER | The Samuel Roberts Noble Foundation, Inc. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1996015239-A2 | ISOFLAVONE REDUCTASE PROMOTER | THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120003273-A1 | SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS | AKR1C3, AKR1C4, SLC10A1 | KDM4E 2194/4885ALDH1A1 1999/4885HPGD 1138/4885 |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | KDM4E 2737/4885ALDH1A1 1629/4885HPGD 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.